Answer
No. It is an oncolytic viral immunotherapy made from a modified herpes simplex virus, although it is an anticancer treatment.
Sources for this answer
- Imlygic — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.